Arcutis Biotherapeutics, Inc.ARQTNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
0.70%
↑ 100% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
-1404.63%
Historical baseline
PeriodValueYoY Change
TTM0.70%+101.3%
2024-55.78%+85.4%
2023-381.56%+95.2%
2022-7991.13%-
20200.00%-
20190.00%-